Avolynt
Research Triangle, NC, US· latest recorded location
AVOLYNT is named on 1 US grants and 5 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 1
- Published applications
- 5
- Inventors
- 5
- Granted in 2026 so far
- 0
- Most recent grant
- 7 Mar 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2021 | 0 | 3 |
| 2022 | 0 | 2 |
| 2023 | 1 | 0 |
By publication year.
Technology areas
Share of 6 documents
Recent patents
- Use of sglt2 inhibitors to treat primary billiary cholangitis8 Dec 2022US 2022/0387467 A1
- Compositions and methods for treating metabolic disease18 Aug 2022US 2022/0257624 A1
- Use of sglt2 inhibitors to treat primary sclerosing cholangitis23 Dec 2021US 2021/0393662 A1
- Method for treating primary sclerosing cholangitis21 Oct 2021US 2021/0322324 A1
- Method for treating post-prandial hypoglycemia25 Mar 2021US 2021/0085701 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.